All News #Library
Biotech
HanAll Initiates Phase 3 VELOS-4 Trial Of Tanfanercept In Dry Eye
03 May 2024 //
PR NEWSWIRE
HanAll Bio Announces Results from VELOS-3 Trial Evaluating Tanfanercept 0.25%
19 May 2023 //
PR NEWSWIRE
HanAll`s Partner Announces Positive Phase 3 Results for Batoclimab
06 Mar 2023 //
PR NEWSWIRE
Korea`s HanAll Biopharma invests in American biotech startup Interon
14 Feb 2023 //
BIOSPECTRUM ASIA

Market Place
Sourcing Support